CEN/TC 206
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 79539 | LVS EN ISO 14155:2020/A11:2024 | Clinical investigation of medical devices for human subjects - Good clinical practice | Standarts spēkā |
| 60724 | LVS EN ISO 10993-16:2018 | Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO 10993-16:2017) | Standarts spēkā |
| 9493 | LVS EN ISO 10993-7:2009 | Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals (ISO 10993-7:2008) | Standarts spēkā |
| 32000 | LVS EN ISO 10993-14:2009 | Biological evaluation of medical devices - Part 14: Identification and quantification of degradation products from ceramics (ISO 10993-14:2001) | Standarts spēkā |
| 74131 | LVS EN ISO 10993-18:2020/A1:2023 | Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process - Amendment 1: Determination of the uncertainty factor (ISO 10993-18:2020/Amd 1:2022) | Standarts spēkā |
| 65481 | EN ISO 22442-2:2020 | Medical devices utilizing animal tissues and their derivatives - Part 2: Controls on sourcing, collection and handling (ISO/DIS 22442-2:2018) | Standarts spēkā |
| 64034 | LVS EN ISO 10993-7:2009/A1:2022 | Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals - Amendment 1: Applicability of allowable limits for neonates and infants (ISO 10993-7:2008/Amd 1:2019) | Standarts spēkā |
| 60721 | LVS EN ISO 10993-1:2021 | Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (ISO 10993-1:2018, including corrected version 2018-11) | Standarts spēkā |
| 65727 | LVS EN ISO 10993-4:2018 | Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood (ISO 10993-4:2017) | Standarts spēkā |
| 25795 | EN ISO 22442-3:2007 | Medical devices utilizing animal tissues and their derivatives - Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents (ISO 22442-3:2007) | Standarts spēkā |
Displaying 151-160 of 194 results.